Author
Broad InstituteORCID 0000-0001-7940-4558Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Kendrick H. Yim, Matías Vergara, Jihyun Lee…·Filipe L.F. Carvalho
The paper identifies genomic features associated with response or resistance to Gem/Doce in BCG-unresponsive NMIBC using whole-exome sequencing and phylogenetic analysis.
David Dewei Yang, Aya Abdelnaser, Jeremiah A. Wala…·Eliezer M. Van Allen
The paper identifies immune spatial organization as a biomarker predicting metastasis risk in high-grade prostate cancer using computational pathology and H&E slides.
Haitham Elmarakeby, Justin H. Hwang, Rand Arafeh…·Eliezer M. Van Allen
This paper introduces a biologically informed deep learning model for prostate cancer classification and identifies molecular drivers of treatment resistance.
Meng Xiao He, Michael S. Cuoco, Jett P. Crowdis…·Eliezer M. Van Allen
This study identifies transcriptional states in mCRPC that mediate treatment resistance, including AR splicing heterogeneity, TGF-β signaling, and immune infiltration patterns.
Deli Liu, Jonathan Evan Shoag, Daniel Poliak…·Christopher E. Barbieri
This study identifies molecular subgroups of BPH and suggests mTOR inhibitors as a potential therapy for specific subtypes.